Back
Sarepta Therapeutics, Inc. Vs. Insmed, Inc. Industry Stock Comparison
Sell
36
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$20.64
Seasonality Move:
10.38%
Sell
40
INSM
Insmed, Inc.
Last Price:
$169.97
Seasonality Move:
7.61%
Sell
36
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $20.34. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Insmed, Inc. (INSM)
is a Sell
Is Insmed, Inc. a Buy, Sell or Hold?
-
The current Insmed, Inc. [INSM] share price is $166.55. The Score for INSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
INSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $20.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
INSM Stock Price Chart
What is Insmed, Inc.'s stock price today?
-
The Insmed, Inc. share price today is $166.55Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight selling pressure.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.92 | Buy |
| Relative Strength Index (14 RSI): | 47.48 | Sell |
| Chaikin Money Flow: | -1746466 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.22 - 22.16) | Buy |
| Bollinger Bands (100): | (17.49 - 22.15) | Buy |
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 29.93 | Sell |
| Chaikin Money Flow: | -270452 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (190.54 - 208.08) | Sell |
| Bollinger Bands (100): | (130.7 - 191.18) | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.62 | Sell |
| 20-day SMA: | 20.83 | Sell |
| 50-day SMA: | 20.82 | Sell |
| 200-day SMA: | 32.48 | Sell |
| 8-day EMA: | 8.17 | Buy |
| 20-day EMA: | 3.76 | Buy |
| 50-day EMA: | 1.59 | Buy |
| 200-day EMA: | 0.41 | Buy |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 192.36 | Sell |
| 20-day SMA: | 199.79 | Sell |
| 50-day SMA: | 186.64 | Sell |
| 200-day SMA: | 121.17 | Buy |
| 8-day EMA: | 191.25 | Sell |
| 20-day EMA: | 194.86 | Sell |
| 50-day EMA: | 184.92 | Sell |
| 200-day EMA: | 135.61 | Buy |
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.60 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.03 per share, and an increase next year of $4.91 per share.
Insmed, Inc. Earnings Growth & INSM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and an increase next year of $2.60 per share.
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Insmed, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||